// App-Quantinova.ai

: Pulmonary arterial hypertension-related morbidity is prognostic for survival: insights from the SERAPHIN and GRIPHON studies

Researchers

Presenter

  • Marius M. Hoeper

Principal Investigators

  • Richard N. Channick

  • Kelly M. Chin

  • Marion Delcroix

  • Sean Gaine

  • Hossein A. Ghofrani

  • Pavel Jansa

  • Irene M. Lang

  • Sanjay Mehta

  • Toms Pulido

  • Bhagavatula K. S. Sastry

  • Grald Simonneau

  • Olivier Sitbon

  • Rogrio Souza

  • Adam Torbicki

  • Victor Tapson

  • Loc Perchenet

  • Ralph Preiss

  • Pierre Verweij

  • Lewis J. Rubin

  • Nazzareno Gali

Medical Centers

  • Department of Respiratory Medicine, Hannover Medical School and German Center of Lung Research, Hannover, Germany,

  • University of Michigan Health System Division of Cardiovascular Medicine, Department of Respiratory Medicine, Hannover Medical School and German Center of Lung Research, Ann Arbor, United States of America

  • Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

  • UT Southwestern Medical Centre - Dallas - United States of America

  • Mater Misericordiae Hospital, Dublin, MA, Ireland

  • University of Giessen and Marburg Lung Center (UGMLC) - Giessen (Germany), and Department of Medicine, Imperial College London, London, United Kingdom

  • Charles Univ and VFN, Prague, Czech Republic

  • Medical University of Vienna, Allgemeines Krankenhaus, Vienna, Austria

  • LHSC University Hospital, London, Canada

  • Ignacio Chávez National Heart Institute, Mexico City, Mexico

  • Omega Hospitals, Hyderabad, India

  • Hopital de Bicetre, Le Kremlin Bicetre, France.

  • INCOR Heart Institute, University of São Paulo, São Paulo, Brazil

  • CMKP European Health Centre, F. Chopin Hospital, Otwock, Poland

  • Cedars-Sinai Medical Center - Los Angeles - United States of America

  • Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

  • Division of Pulmonary and Critical Care Medicine University of California, San Diego Medical School, San Diego, United States of America

  • Istituto di Malattie dell'Apparato Cardiovascolare, Università di Bologna, Bologna, Italy

Locations

  • Germany

  • United States

  • Belgium

  • Ireland

  • United Kingdom

  • Czech Republic

  • Austria

  • Canada

  • Mexico

  • India

  • France

  • Brazil

  • Poland

  • Switzerland

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved